MSH|^~\&|Test EHR Application|X68||NIST Test Iz Reg|201207010822||VXU^V04^VXU_V04|NIST-IZ-006.00|P|2.5.1|||AL|ERPID|1||MR-356^^^MAA^MR~184-25-4562^^^MAA^SS||Quinla^Eisig^^^^^L||19410714|M|||||^~^NET^^Eisig@hotmail.comORC|RE||IZ-783275^NDA|||||||||57422^RADON^NICHOLAS^^^^^^NDA^LRXA|0|1|20120816||115^Tdap^CVX|0.5|mL^MilliLiter [SI Volume Units]^UCUM||00^New immunization record^NIP001||^^^0||||Z79YG|20121216|SKB^GlaxoSmithKline^MVX|||CP|ARXR|C28161^Intramuscular^NCIT|RD^Right Arm^HL70163OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20120814|||VXC40^Eligibility captured at the immunization level^CDCPHINVSOBX|2|CE|30956-7^vaccine type^LN|2|139^Td(adult) unspecified formulation^CVX||||||FOBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20130509||||||FOBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20120816||||||F